These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7090422)

  • 41. Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity.
    Sazuka Y; Tanizawa H; Takino Y
    Jpn J Cancer Res; 1989 Oct; 80(10):1000-5. PubMed ID: 2482282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.
    Israel M; Wilkinson PM; Pegg WJ; Frei E
    Cancer Res; 1978 Feb; 38(2):365-70. PubMed ID: 620407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling the metabolism of idarubicin to idarubicinol in rat heart: effect of rutin and phenobarbital.
    Kang W; Weiss M
    Drug Metab Dispos; 2003 Apr; 31(4):462-8. PubMed ID: 12642473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia.
    Paul C; Baurain R; Gahrton G; Peterson C
    Cancer Lett; 1980 Jun; 9(4):263-9. PubMed ID: 6930988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.
    Han G; Israel M; Seshadri R; Dalton JT; Sweatman TW
    Cancer Chemother Pharmacol; 1996; 37(5):472-8. PubMed ID: 8599871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic metabolism of doxorubicin in mice and rats.
    Vrignaud P; Londos-Gagliardi D; Robert J
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):101-5. PubMed ID: 3770010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.
    Krishan A; Ganapathi R
    Cancer Res; 1980 Nov; 40(11):3895-900. PubMed ID: 6937236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.
    Formelli F; Casazza AM; Di Marco A; Mariani A; Pollini C
    Cancer Chemother Pharmacol; 1979; 3(4):261-9. PubMed ID: 294954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of daunorubicin and doxorubicin with DNA and chromatin.
    Zunino F; Di Marco A; Zaccara A; Gambetta RA
    Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbial metabolism of anthracycline antibiotics daunomycin and adriamycin.
    Marshall VP; McGovren JP; Richard FA; Richard RE; Wiley PF
    J Antibiot (Tokyo); 1978 Apr; 31(4):336-42. PubMed ID: 26650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.
    Graves DE; Krugh TR
    Biochemistry; 1983 Aug; 22(16):3941-7. PubMed ID: 6615810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.
    Smith BJ; Kundv D
    Br J Cancer; 1976 Feb; 33(2):232-3. PubMed ID: 1259917
    [No Abstract]   [Full Text] [Related]  

  • 54. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The embryotoxicity of adriamycin in rat embryos in vitro.
    Fantel AG; Greenaway JC; Juchau MR
    Toxicol Appl Pharmacol; 1985 Aug; 80(1):155-65. PubMed ID: 4024103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
    Di Fronzo G; Gambetta RA; Lenaz L
    Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
    [No Abstract]   [Full Text] [Related]  

  • 57. Enzymatic activation and binding of adriamycin to nuclear DNA.
    Sinha BK; Trush MA; Kennedy KA; Mimnaugh EG
    Cancer Res; 1984 Jul; 44(7):2892-6. PubMed ID: 6327028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenobarbital-digitoxin interaction in the guinea pig liver.
    Carvalhas ML; Figueira MA; Maya MR
    Eur J Drug Metab Pharmacokinet; 1982; 7(3):165-71. PubMed ID: 7173270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of anthracycline concentrations in S180 cell lines of varying sensitivity.
    Siegfried JM; Tritton TR; Sartorelli AC
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1133-41. PubMed ID: 6684559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.